This brand name is authorized in France.
The drug ALCAPHOR contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
Y370FA4B4G - TROMETAMOL CITRATE
|
|
Trometamol acts as a proton acceptor and prevents or corrects acidosis by actively binding hydrogen ions (H+). Tromethamine also acts as an osmotic diuretic, increasing urine flow, urinary pH, and excretion of fixed acids, carbon dioxide and electrolytes. It is used for the prevention and correction of metabolic acidosis. |
|
2
|
UNII
6FO62KCQ7A - DISODIUM HYDROGEN CITRATE
|
|
Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section. |
|
3
|
UNII
4UQD42S065 - DIPOTASSIUM HYDROGEN CITRATE
|
|
Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FR | Base de données publique des médicaments | 62691806 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.